XML 28 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 71 Months Ended
Aug. 11, 2017
Aug. 03, 2012
Apr. 30, 2018
Oct. 27, 2017
Aug. 31, 2017
Aug. 25, 2016
Jun. 01, 2016
Mar. 31, 2016
Sep. 30, 2017
Jun. 30, 2018
Dec. 31, 2016
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Jul. 14, 2017
Mar. 31, 2017
Aug. 31, 2016
Related Party Transaction [Line Items]                                  
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures   $ 6,000,000               $ 6,000,000   $ 6,000,000     $ 1,000,000    
Joint Venture Investments In Voting Common Ownership Units (in shares)   600,000                              
Joint Venture Investments In Non Voting Preferred Ownership Units   5,000,000                              
Development Activities Monthly Fee   $ 63,000                              
Joint Venture, Operating Expenses, Inter Company Transactions                   965,000   8,686,000          
Joint Venture, Operating Expenses Allocated To Company                   965,000   7,074,000          
Percentage Of Non Royalty Income 5.00%                                
Conversion of Stock, Shares Converted 3,500,000             1,500,000                  
Conversion of Stock, Shares Issued               120,000                  
Joint Venture Method Investment Ownership Percentage   60.00%                              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           33,088                      
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 10.70                      
Management Fees             $ 80,000                    
Professional Fees             $ 10,000                    
Accrued Professional Fees         $ 20,000                        
Conversion of Stock, Amount Converted $ 3,500,000                                
Conversion of Stock, Amount Issued $ 1,000,000                                
Interest Payable                   140,000   140,000   $ 68,000      
Other Assets, Current                   $ 11,000   11,000   $ 98,000      
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant   83,480                              
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage                   50.00%              
Payment for Management Fee     $ 50,000                            
Common Stock [Member]                                  
Related Party Transaction [Line Items]                                  
Joint Venture Losses Recognition Criteria, Common Ownership Equity                   $ 0   $ 0          
Preferred Stock [Member]                                  
Related Party Transaction [Line Items]                                  
Noncontrolling Interest, Ownership Percentage by Parent                   100.00%   100.00%          
Noncontrolling Interest [Member]                                  
Related Party Transaction [Line Items]                                  
Noncontrolling interests                       $ 667,000          
Exclusive License Agreement [Member]                                  
Related Party Transaction [Line Items]                                  
Percentage Of Royalty Payment 3.00%                                
Annual Maintenance Payments $ 25,000                                
Maximum [Member]                                  
Related Party Transaction [Line Items]                                  
Joint Venture Method Investment Ownership Percentage               64.00%                  
Maximum [Member] | Exclusive License Agreement [Member]                                  
Related Party Transaction [Line Items]                                  
Milestone Payments 500,000                                
Royalty Expense 1,000,000                                
Minimum [Member]                                  
Related Party Transaction [Line Items]                                  
Joint Venture Method Investment Ownership Percentage               60.00%                  
Minimum [Member] | Exclusive License Agreement [Member]                                  
Related Party Transaction [Line Items]                                  
Milestone Payments 50,000                                
Royalty Expense $ 500,000                                
Lipimetix [Member]                                  
Related Party Transaction [Line Items]                                  
Joint Venture Investments Common Ownership Units, Co-venture (in shares)   400,000                              
Ownership Percentage Co-venture   40.00%                              
Noncontrolling interests                   $ (667,000)              
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)   $ 378,000               $ 378,000              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                   81,479              
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                   $ 1.07              
Voting Common Ownership Units [Member]                                  
Related Party Transaction [Line Items]                                  
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures   1,000,000                              
Non Voting Preferred Ownership Units [Member]                                  
Related Party Transaction [Line Items]                                  
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures   $ 5,000,000                              
MrHolliman [Member]                                  
Related Party Transaction [Line Items]                                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross       14,126                          
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price       $ 10.70                          
Ownership As Converted [Member]                                  
Related Party Transaction [Line Items]                                  
Joint Venture Method Investment Ownership Percentage                   65.11%              
Ownership As Converted [Member] | Lipimetix [Member]                                  
Related Party Transaction [Line Items]                                  
Equity Method Investment, Ownership Percentage   69.75%               60.00%   60.00%          
Ownership as converted including options and warrants [Member]                                  
Related Party Transaction [Line Items]                                  
Joint Venture Method Investment Ownership Percentage       64.31%                          
Series B2 Preferred Stock [Member]                                  
Related Party Transaction [Line Items]                                  
Joint Venture Losses Recognition Criteria, Common Ownership Equity           $ 946,000                     $ (946,000)
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs           1,012,000                      
Proceeds from Issuance of Preferred Stock and Preference Stock   $ 15,000       946,000                      
Stock Issued During Period, Shares, Acquisitions 93,458                                
Stock Issued During Period, Value, Acquisitions $ 1,000,000                                
Series B1 And B2 Preferred Stock [Member]                                  
Related Party Transaction [Line Items]                                  
Joint Venture Method Investment Ownership Percentage   62.20%                              
Series B1 Preferred Stock [Member]                                  
Related Party Transaction [Line Items]                                  
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs           1,012,000                      
Proceeds from Issuance of Preferred Stock and Preference Stock           946,000                      
Payments of Stock Issuance Costs           $ 66,000                      
Stock Issued During Period, Shares, New Issues           94,537                      
Management Fees         $ 300,000           $ 300,000            
Professional Fees                     60,000            
Management Fee Expense                 $ 150,000   $ 250,000            
Other Commitment, Due in Second Year                         $ 150,000        
Accrued Professional Fees                               $ 50,000  
Revolving Credit Facility [Member]                                  
Related Party Transaction [Line Items]                                  
Long-term Line of Credit                   $ 1,680,000   $ 1,680,000          
Interest Payable                   $ 80,000   $ 80,000